Frailty and metabolic syndrome (MetS) are common conditions in older adults and may share overlapping pathophysiological pathways that impact mortality.
Objectives:
We aimed to investigate the effect of frailty and MetS on mortality the older adults.
Methods:
This study included 1100 outpatients aged ≥60 years. We followed the participants for five years, during which 13.2% of them died. The status of MetS was assessed using the criteria established by the National Cholesterol Education Program Third Adult Treatment Panel. We evaluated frailty using the FRAIL scale.
Results:
Mean age was 71.57 ± 7.09 years. The frail group had a significantly higher mean age (73.13 ± 7.75) compared to the nonfrail (70.20 ± 6.23) and prefrail (70.86 ± 6.73) groups (P < 0.001). In all three groups, women made up the majority, but in the frail group (76.9%), there were significantly more women than other groups (P < 0.001). MetS was more prevalent in prefrail and frail groups compared to those who were nonfrail (nonfrail: %59.1, prefrail: %71, frail: %70.2) (P = 0.010). The frail group showed a higher frequency of cognitive impairment, depressive mood, malnutrition, and dependency. The overall mortality rate for the sample was 13.2%, as anticipated, the frail group has a significantly higher mortality rate (23.4%) compared to the other two groups (nonfrail: 5.3%, prefrail: 10.2%) (P < 0.001). The Cox proportional hazards model indicated that the frail group demonstrated an increased mortality risk over five years, even after adjusting for age, sex, and metabolic disorders (hazard ratio: 4.44, 95% confidence interval = 2.19–9.02, P < 0.001).
Conclusions:
Frailty was a more accurate predictor of mortality than MetS, regardless of age.
AlbertiKG, ZimmetP, ShawJ. Metabolic syndrome–a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med, 2006; 23(5):469–480; doi: 10.1111/j.1464-5491.2006.01858.x
2.
MooreJX, ChaudharyN, AkinyemijuT. Peer reviewed: Metabolic syndrome prevalence by race/ethnicity and sex in the United States, National Health and Nutrition Examination Survey, 1988–2012. Prev Chronic Dis, 2017; 14.
3.
NolanPB, Carrick-RansonG, StinearJW, et al.Prevalence of metabolic syndrome and metabolic syndrome components in young adults: A pooled analysis. Prev Med Rep, 2017; 7:211–215.
4.
FahedG, AounL, Bou ZerdanM, et al.Metabolic syndrome: Updates on pathophysiology and management in 2021. Int J Mol Sci, 2022; 23(2):786.
5.
UN D. World Population Prospects: The 2012 Revision. UN Department of Economic and Social Affairs; 2013.
DentE, MorleyJ, Cruz-JentoftA, et al.Physical frailty: ICFSR international clinical practice guidelines for identification and management. J Nutr Health Aging, 2019; 23(9):771–787.
8.
FriedLP, TangenCM, WalstonJ, et al.; Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci, 2001; 56(3):M146–M156.
9.
KojimaG, IliffeS, JivrajS, et al.Association between frailty and quality of life among community-dwelling older people: A systematic review and meta-analysis. J Epidemiol Community Health, 2016; 70(7):716–721.
10.
SoysalP, VeroneseN, ThompsonT, et al.Relationship between depression and frailty in older adults: A systematic review and meta-analysis. Ageing Res Rev, 2017; 36:78–87.
11.
GillTM, GahbauerEA, AlloreHG, et al.Transitions between frailty states among community-living older persons. Arch Intern Med, 2006; 166(4):418–423.
12.
StoutMB, JusticeJN, NicklasBJ, et al.Physiological aging: Links among adipose tissue dysfunction, diabetes, and frailty. Physiology (Bethesda), 2017; 32(1):9–19.
13.
ZhangZ, ZhangP, ZhangF, et al.Genetic insights into the risk of frailty on metabolic syndrome and its components: Bidirectional Mendelian randomization study. Nutr Metab Cardiovasc Dis, 2025; 35(7):103898.
14.
BuchmannN, SpiraD, KönigM, et al.Frailty and the metabolic syndrome—results of the berlin aging study ii (base-ii). J Frailty Aging, 2019; 8(4):169–175.
15.
ChodeS, MalmstromT, MillerD, et al.Frailty, diabetes, and mortality in middle-aged African Americans. J Nutr Health Aging, 2016; 20(8):854–859.
16.
LiawF-Y, KaoT-W, WuL-W, et al.Components of metabolic syndrome and the risk of disability among the elderly population. Sci Rep, 2016; 6(1):22750.
17.
HoogendijkEO, HuismanM, van BallegooijenAJ. The role of frailty in explaining the association between the metabolic syndrome and mortality in older adults. Exp Gerontol, 2017; 91:5–8.
18.
Detection NCEPEPo, Adults ToHBCi. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). The Program, 2002.
19.
GrundySM, CleemanJI, DanielsSR, et al.; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation, 2005; 112(17):2735–2752.
20.
MorleyJE, MalmstromT, MillerD. A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J Nutr Health Aging, 2012; 16(7):601–608.
21.
GüngenC, ErtanT, EkerE, et al.Standardize mini mental test’in Türk toplumunda hafif demans tan› s› nda geçerlik ve güvenilirliği. Türk Psikiyatri Dergisi, 2002; 13(4):273–281.
22.
MolloyDW, AlemayehuE, RobertsR. Reliability of a standardized mini-mental state examination compared with the traditional mini-mental state examination. Am J Psychiatry, 1991; 148(1):102–105.
23.
YesavageJA, BrinkTL, RoseTL, et al.Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res, 1982; 17(1):37–49.
24.
ErtanT, EkerE. Reliability, validity, and factor structure of the Geriatric Depression Scale in Turkish elderly: Are there different factor structures for different cultures? Int Psychogeriatr, 2000; 12(2):163–172.
25.
KatzS, AkpomCA. 12. Index of ADL. Med Care, 1976; 14(5 Suppl):116–118.
26.
LawtonM, BrodyEM. Assessment of older people: Self-maintaining and instrumental activities of daily living. Nursing Research, 1970; 19(3):278.
27.
SarikayaD, HalilM, KuyumcuME, et al.Mini nutritional assessment test long and short form are valid screening tools in Turkish older adults. Arch Gerontol Geriatr, 2015; 61(1):56–60.
28.
HaoQ, SongX, YangM, et al.Understanding risk in the oldest old: Frailty and the metabolic syndrome in a Chinese community sample aged 90+ years. J Nutr Health Aging, 2016; 20(1):82–88.
29.
KaneAE, GregsonE, TheouO, et al.The association between frailty, the metabolic syndrome, and mortality over the lifespan. Geroscience, 2017; 39(2):221–229.
30.
AhmadiS-F, StrejaE, ZahmatkeshG, et al.Reverse epidemiology of traditional cardiovascular risk factors in the geriatric population. J Am Med Dir Assoc, 2015; 16(11):933–939.
31.
Saifuddin EkramARM, EspinozaSE, ErnstME, et al.The Association between Metabolic Syndrome, Frailty and disability-free survival in Healthy Community-dwelling older adults. J Nutr Health Aging, 2023; 27(1):1–9.
32.
PengY, ZhongG-C, ZhouX, et al.Frailty and risks of all-cause and cause-specific death in community-dwelling adults: A systematic review and meta-analysis. BMC Geriatr, 2022; 22(1):725.
33.
Santamaría-UlloaC, LehningAJ, Cortés-OrtizMV, et al.Frailty as a predictor of mortality: A comparative cohort study of older adults in Costa Rica and the United States. BMC Public Health, 2023; 23(1):1960.
34.
MuscedereJ, BagshawSM, KhoM, et al.; Canadian Critical Care Trials Group. Frailty, Outcomes, Recovery and Care Steps of Critically Ill Patients (FORECAST): A prospective, multi-centre, cohort study. Intensive Care Med, 2024; 50(7):1064–1074.
35.
YangY, ChenB, DengM, et al.The prevalence of frailty among patients with metabolic syndrome: A systematic review and meta-analysis. Contemp Nurse, 2024; 60(5):479–495.
36.
ChapmanIM. Obesity paradox during aging. Body Composition and Aging, 2010; 37:20–36.
37.
JuS-Y, LeeJ-Y, KimD-H. Association of metabolic syndrome and its components with all-cause and cardiovascular mortality in the elderly: A meta-analysis of prospective cohort studies. Medicine (Baltimore), 2017; 96(45):e8491.
38.
van HerptTT, DehghanA, van HoekM, et al.The clinical value of metabolic syndrome and risks of cardiometabolic events and mortality in the elderly: The Rotterdam study. Cardiovasc Diabetol, 2016; 15:69–10.
39.
ViscogliosiG. The metabolic syndrome: A risk factor for the frailty syndrome? J Am Med Dir Assoc, 2016; 17(4):364–366.
40.
McCarthyK, LairdE, O’HalloranAM, et al.Association between metabolic syndrome and risk of both prevalent and incident frailty in older adults: Findings from The Irish Longitudinal Study on Ageing (TILDA). Exp Gerontol, 2023; 172:112056.
41.
NishidaY, YamadaY, SasakiS, et al.Effect of overweight/obesity and metabolic syndrome on frailty in middle‐aged and older Japanese adults. Obes Sci Pract, 2024; 10(1):e714.
42.
HoogendijkEO, AfilaloJ, EnsrudKE, et al.Frailty: İmplications for clinical practice and public health. Lancet, 2019; 394(10206):1365–1375.
43.
ZengP, LiM, CaoJ, et al.Association of metabolic syndrome severity with frailty progression among Chinese middle and old-aged adults: a longitudinal study. Cardiovasc Diabetol, 2024; 23(1):302.
44.
de SouzaM, da Silva RochaG, de Souza SampaioE, et al.Metabolic syndrome and positive frailty screening: A cross-sectional study with community-dwelling older adults. JAR Life, 2024; 13:82–87.
